Bioptigen, Inc. is a new class of in vivo optical imaging technology allowing researchers and clinicians to see pathologies at their earliest stages. The sophisticated SDOCT hardware and software system enables real-time non invasive imaging of internal tissue microstructure at an unmatched level of precision and depth. Bioptigen’s system extends the application space to cover a wide range of human and animal subjects. These advances make it possible for researchers to open up new avenues of biological exploration and development, and clinicians to foster advances in disease detection and management.